Full Text View
Tabular View
No Study Results Posted
Related Studies
REVEAL: Reduction of Infarct Expansion and Ventricular Remodeling With Erythropoietin After Large Myocardial Infarction
This study has been completed.
Study NCT00378352   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 18, 2006.   Last Updated on June 28, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Infarction
Myocardial Infarction
Ventricular Remodeling
More general conditions related to this trial
Cardiovascular Diseases
Heart Diseases
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Pathological Conditions, Anatomical
Vascular Diseases
Interventions listed in this trial
Epoietin Alfa
Placebo
Additional drug interventions recognized in this trial
Epoetin Alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute on Aging (NIA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services